Zoltan Antal, M.D.

Pediatric Endocrinology

Zoltan Antal, M.D.

Recognizing the inherent difficulties in dealing with challenging and often lifelong illnesses in pediatric endocrinology,I strive to get to know my patients and their families personally. Emphasizing family involvement while simultaneously promotinga child’s individuality, growth and independence often results in excellent outcomes. I believe honesty and open andclear communication are the most important components of a healthy relationship between a patient and their doctor.

Dr. Zoltan Antal is the Director of the Pediatric Diabetes Program in the Division of Pediatric Endocrinology, and an Assistant Professor of Pediatrics at Weill Cornell Medical College.  He is also an Assistant Attending Pediatrician at NewYork-Presbyterian Hospital.  He is board certified in Pediatrics and Pediatric Endocrinology.
 
Dr. Antal received a B.S. in Biology from Stony Brook University in Stony Brook, New York and completed his medical degree (M.D.) from St. George’s University School of Medicine in Grenada, West Indies in combination with clinical rotations at Jamaica Hospital in Queens, New York City. He went on to complete his Residency in Pediatrics in Brooklyn, New York at SUNY Downstate Medical Center and Kings County Hospital, where he later served as chief resident. After residency, he remained in New York City and completed a fellowship in Pediatric Endocrinology at the Children’s Hospital at Montefiore in the Bronx.
 
During his fellowship, Dr. Antal also conducted research at the Albert Einstein College of Medicine in the immunology of diabetes. Specifically, he isolated islet cells from pancreata of diabetic mice and studied the targets of the islet infiltrating T cells. In addition, he was also in charge of the translational component of the research, which entailed examining the peripheral blood of children newly diagnosed with type 1 diabetes, searching for reactivity to the human counterparts of the murine T cell targets.
 
Finally, Dr. Antal and his colleagues analyzed the HLA supertypes of a subset of diabetic children, publishing the findings in the Annals of the New York Academy of Sciences in 2008.

Back to topBack To Top